• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗体调理细胞被补体膜攻击复合物穿透后会促进钙离子内流并诱导丝状体形成。

Penetration of antibody-opsonized cells by the membrane attack complex of complement promotes Ca(2+) influx and induces streamers.

机构信息

Department of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, Charlottesville, VA, USA.

出版信息

Eur J Immunol. 2011 Aug;41(8):2436-46. doi: 10.1002/eji.201041204. Epub 2011 Jul 4.

DOI:10.1002/eji.201041204
PMID:21674476
Abstract

We have reported that during complement-mediated cytolysis of B cells promoted by the CD20 mAbs rituximab or ofatumumab (OFA), long, thin structures that we call streamers (≥ 3 cell diameters) are rapidly generated and grow out from the cell surface. Streamers appear before cells are killed and contain opsonizing mAbs and membrane lipids. By exploiting the differential Ca(2+) requirements of discrete steps in the complement cascade, we determined that mAb-opsonized cells first tagged with C3b using C5-depleted serum are killed on addition of serum and EDTA, but the cells do not produce streamers. Also, cells first opsonized with OFA are lysed in serum containing Mg-EGTA by the alternative complement pathway but streamers are not produced. These findings indicate that Ca(2+) influx is necessary for streamer formation. Other mAbs that promote complement-mediated cytolysis also induce streamers on target cells. Streamer-like structures called nanotubes have been reported in several cellular systems, and are thought to promote intercellular communication/signaling. We tested whether this signaling could influence the susceptibility of neighboring cells contacted by streamers to complement attack and found that complement-mediated cytolysis of OFA-opsonized cells increases the resistance of unopsonized indicator cell populations to subsequent lysis when these cells are exposed to OFA and complement.

摘要

我们曾报道,在 CD20 单抗利妥昔单抗或奥法木单抗(OFA)促进的 B 细胞补体介导的细胞溶解过程中,会迅速产生并从细胞膜表面伸出长而细的结构,我们称之为“streamers”(≥3 个细胞直径)。streamers 出现在细胞被杀死之前,包含调理抗体和膜脂质。通过利用补体级联反应中不同步骤的差异 Ca(2+)需求,我们确定首先使用 C5 耗尽血清对 mAb 调理的细胞进行 C3b 标记,然后加入血清和 EDTA 会杀死细胞,但不会产生 streamers。同样,首先用 OFA 调理的细胞在含有 Mg-EGTA 的血清中通过替代补体途径被裂解,但不会产生 streamers。这些发现表明 Ca(2+)内流对于 streamer 的形成是必要的。其他促进补体介导的细胞溶解的 mAbs 也会在靶细胞上诱导产生 streamers。在几个细胞系统中已经报道了称为纳米管的类似 streamer 的结构,并且被认为可以促进细胞间的通讯/信号转导。我们测试了这种信号是否可以影响接触 streamers 的相邻细胞对补体攻击的敏感性,发现当这些细胞暴露于 OFA 和补体时,OFA 调理的细胞的补体介导的细胞溶解增加了未调理的指示细胞群体对随后裂解的抗性。

相似文献

1
Penetration of antibody-opsonized cells by the membrane attack complex of complement promotes Ca(2+) influx and induces streamers.抗体调理细胞被补体膜攻击复合物穿透后会促进钙离子内流并诱导丝状体形成。
Eur J Immunol. 2011 Aug;41(8):2436-46. doi: 10.1002/eji.201041204. Epub 2011 Jul 4.
2
Complement activation on B lymphocytes opsonized with rituximab or ofatumumab produces substantial changes in membrane structure preceding cell lysis.利妥昔单抗或奥法木单抗致敏的B淋巴细胞上的补体激活在细胞裂解前会导致膜结构发生显著变化。
J Immunol. 2008 Jul 1;181(1):822-32. doi: 10.4049/jimmunol.181.1.822.
3
Binding of submaximal C1q promotes complement-dependent cytotoxicity (CDC) of B cells opsonized with anti-CD20 mAbs ofatumumab (OFA) or rituximab (RTX): considerably higher levels of CDC are induced by OFA than by RTX.亚最大量C1q的结合促进了用抗CD20单克隆抗体奥法木单抗(OFA)或利妥昔单抗(RTX)调理的B细胞的补体依赖性细胞毒性(CDC):与RTX相比,OFA诱导的CDC水平要高得多。
J Immunol. 2009 Jul 1;183(1):749-58. doi: 10.4049/jimmunol.0900632. Epub 2009 Jun 17.
4
Alternative complement pathway-mediated myeloid cell cytotoxicity: repertoire of membrane factors participating in regulation of C3 deposition and cytolysis.替代补体途径介导的髓样细胞细胞毒性:参与C3沉积和细胞溶解调节的膜因子库。
Eur J Immunol. 1991 Aug;21(8):1787-92. doi: 10.1002/eji.1830210802.
5
An anti-C3b(i) mAb enhances complement activation, C3b(i) deposition, and killing of CD20+ cells by rituximab.一种抗C3b(i)单克隆抗体可增强补体激活、C3b(i)沉积以及利妥昔单抗对CD20+细胞的杀伤作用。
Blood. 2003 Feb 1;101(3):1071-9. doi: 10.1182/blood-2002-03-0876. Epub 2002 Sep 5.
6
Complement activation and C3b deposition on rituximab-opsonized cells substantially blocks binding of phycoerythrin-labeled anti-mouse IgG probes to rituximab.补体激活以及补体C3b在利妥昔单抗调理的细胞上的沉积,会显著阻断藻红蛋白标记的抗小鼠IgG探针与利妥昔单抗的结合。
J Immunol Methods. 2004 Nov;294(1-2):37-42. doi: 10.1016/j.jim.2004.08.004.
7
Complement-Dependent Activity of CD20-Specific IgG Correlates With Bivalent Antigen Binding and C1q Binding Strength.补体依赖性 CD20 特异性 IgG 活性与二价抗原结合和 C1q 结合强度相关。
Front Immunol. 2021 Jan 11;11:609941. doi: 10.3389/fimmu.2020.609941. eCollection 2020.
8
Ofatumumab is more efficient than rituximab in lysing B chronic lymphocytic leukemia cells in whole blood and in combination with chemotherapy.奥法妥木单抗在裂解全血中的 B 慢性淋巴细胞白血病细胞方面比利妥昔单抗更有效,并且与化疗联合使用时也是如此。
J Immunol. 2013 Jan 1;190(1):231-9. doi: 10.4049/jimmunol.1202645. Epub 2012 Dec 5.
9
Mapping of binding epitopes of a human decay-accelerating factor monoclonal antibody capable of enhancing rituximab-mediated complement-dependent cytotoxicity.一种能够增强利妥昔单抗介导的补体依赖性细胞毒性的人衰变加速因子单克隆抗体结合表位的定位
Clin Immunol. 2008 Aug;128(2):155-63. doi: 10.1016/j.clim.2008.03.507. Epub 2008 May 23.
10
Real-time analysis of the detailed sequence of cellular events in mAb-mediated complement-dependent cytotoxicity of B-cell lines and of chronic lymphocytic leukemia B-cells.单克隆抗体介导的B细胞系和慢性淋巴细胞白血病B细胞补体依赖性细胞毒性中细胞事件详细序列的实时分析。
Mol Immunol. 2016 Feb;70:13-23. doi: 10.1016/j.molimm.2015.12.007. Epub 2015 Dec 12.

引用本文的文献

1
Analysis of complement deposition and processing on Chlamydia trachomatis.分析沙眼衣原体上补体的沉积和加工。
Med Microbiol Immunol. 2021 Feb;210(1):13-32. doi: 10.1007/s00430-020-00695-x. Epub 2020 Nov 18.
2
The Role of Complement in the Mechanism of Action of Therapeutic Anti-Cancer mAbs.补体在治疗性抗癌单克隆抗体作用机制中的作用
Antibodies (Basel). 2020 Oct 28;9(4):58. doi: 10.3390/antib9040058.
3
How Do mAbs Make Use of Complement to Kill Cancer Cells? The Role of Ca.单克隆抗体如何利用补体来杀死癌细胞?钙的作用。
Antibodies (Basel). 2020 Sep 4;9(3):45. doi: 10.3390/antib9030045.
4
Nanoparticles Targeting STATs in Cancer Therapy.纳米颗粒在癌症治疗中靶向 STATs。
Cells. 2019 Sep 27;8(10):1158. doi: 10.3390/cells8101158.
5
Complement C5b-9 and Cancer: Mechanisms of Cell Damage, Cancer Counteractions, and Approaches for Intervention.补体 C5b-9 与癌症:细胞损伤的机制、癌症的拮抗作用及干预方法。
Front Immunol. 2019 Apr 10;10:752. doi: 10.3389/fimmu.2019.00752. eCollection 2019.
6
Decoration of Anti-CD38 on Nanoparticles Carrying a STAT3 Inhibitor Can Improve the Therapeutic Efficacy Against Myeloma.携带STAT3抑制剂的纳米颗粒上抗CD38的修饰可提高对骨髓瘤的治疗效果。
Cancers (Basel). 2019 Feb 20;11(2):248. doi: 10.3390/cancers11020248.
7
Receptor-Interacting Protein Kinases 1 and 3, and Mixed Lineage Kinase Domain-Like Protein Are Activated by Sublytic Complement and Participate in Complement-Dependent Cytotoxicity.受体相互作用蛋白激酶 1 和 3 以及混合谱系激酶结构域样蛋白被亚溶血性补体激活,并参与补体依赖性细胞毒性。
Front Immunol. 2018 Feb 23;9:306. doi: 10.3389/fimmu.2018.00306. eCollection 2018.
8
Emerging drugs and combinations to treat multiple myeloma.治疗多发性骨髓瘤的新型药物及联合用药方案
Oncotarget. 2017 Jul 15;8(36):60656-60672. doi: 10.18632/oncotarget.19269. eCollection 2017 Sep 1.
9
Low pH impairs complement-dependent cytotoxicity against IgG-coated target cells.低pH值会损害针对IgG包被靶细胞的补体依赖性细胞毒性。
Oncotarget. 2016 Nov 8;7(45):74203-74216. doi: 10.18632/oncotarget.12412.
10
Antibodies That Efficiently Form Hexamers upon Antigen Binding Can Induce Complement-Dependent Cytotoxicity under Complement-Limiting Conditions.抗原结合后能有效形成六聚体的抗体在补体限制条件下可诱导补体依赖的细胞毒性。
J Immunol. 2016 Sep 1;197(5):1762-75. doi: 10.4049/jimmunol.1600648. Epub 2016 Jul 29.